Name:
Omeprazole
Type:
Proton pump inhibitor
AKA:
Prilosec, Losec
Omeprazole image
Synthetic substance, no natural derivative
IUPAC Logo
Omeprazole image
Omeprazole, a proton pump inhibitor used to treat acid reflux and peptic ulcers, was first marketed by AstraZeneca in 1988. It works by reducing stomach acid production and has become one of the most commonly prescribed medications worldwide. Omeprazole is synthesized in laboratories, marking a significant advancement in gastrointestinal treatment. Its development has greatly improved the management of acid-related disorders, with a broad impact on global healthcare practices.
Synthetic Substances Image
Omeprazole, a proton pump inhibitor (PPI), reduces stomach acid production. It acts as a downer, alleviating conditions like GERD and peptic ulcers by decreasing stomach acid. Short-term use is generally safe, but long-term use can lead to issues like bone fractures, kidney disease, and vitamin B12 deficiency. Overdose can cause nausea, vomiting, and confusion. Safe doses are typically between 20-40 mg daily. Recent findings suggest that while PPIs are effective for acid-related disorders, their long-term use should be monitored due to potential side effects.
N/A
Omeprazole, a proton pump inhibitor, is primarily used for gastric acid reduction and has minimal direct psychological effects. Indirectly, long-term use might influence mental well-being through gut-brain axis interactions. Research mainly focuses on its impact on gastrointestinal health and potential side effects rather than significant psychological effects.
N/A
Omeprazole, a proton pump inhibitor, revolutionized the treatment of gastric acid-related conditions since its introduction in the late 20th century. While it lacks the rich cultural lore of older substances, its impact on modern healthcare is profound. Widely used across the globe, it represents advancements in pharmaceuticals, easing conditions that once required invasive surgeries. Its role in modern medicine underscores the shift towards preventive care and chronic disease management. Despite its benefits, there are debates over long-term usage and potential side effects, highlighting the ongoing discourse in medical communities about balancing efficacy and safety in pharmacotherapy.
N/A